0001736243-26-000001.txt : 20260429 0001736243-26-000001.hdr.sgml : 20260429 20260429161711 ACCESSION NUMBER: 0001736243-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260429 DATE AS OF CHANGE: 20260429 EFFECTIVENESS DATE: 20260429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Acurx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001736243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-582296 FILM NUMBER: 26916335 BUSINESS ADDRESS: STREET 1: 259 LIBERTY AVENUE CITY: STATEN ISLAND STATE: NY ZIP: 10305 BUSINESS PHONE: 917-533-1469 MAIL ADDRESS: STREET 1: 259 LIBERTY AVENUE CITY: STATEN ISLAND STATE: NY ZIP: 10305 FORMER COMPANY: FORMER CONFORMED NAME: Acurx Pharmaceuticals, LLC DATE OF NAME CHANGE: 20180402 D 1 primary_doc.xml X0708 D LIVE 0001736243 Acurx Pharmaceuticals, Inc. 259 LIBERTY AVENUE STATEN ISLAND NY NEW YORK 10305 917-533-1469 DELAWARE Acurx Pharmaceuticals, LLC Corporation true David P. Luci 259 Liberty Ave. Staten Island NY NEW YORK 10305 Executive Officer Director Robert J. DeLuccia 259 Liberty Ave. Staten Island NY NEW YORK 10305 Executive Officer Director Robert G. Shawah 259 Liberty Ave. Staten Island NY NEW YORK 10305 Executive Officer Jack H. Dean 259 Liberty Ave. Staten Island NY NEW YORK 10305 Director James Donohue 259 Liberty Ave. Staten Island NY NEW YORK 10305 Director Thomas Harrison 259 Liberty Ave. Staten Island NY NEW YORK 10305 Director Carl Sailer 259 Liberty Ave. Staten Island NY NEW YORK 10305 Director Joseph Scodari 259 Liberty Ave. Staten Island NY NEW YORK 10305 Director Pharmaceuticals Decline to Disclose 06b false 2026-04-15 false true false 0 4587473 4587473 0 The Total Offering amount reflects the aggregate exercise price of the warrants. false 5 0 0 0 false Acurx Pharmaceuticals, Inc. /s/David P. Luci David P. Luci President and CEO 2026-04-29